Eurelings Marijke, Frijns Catharina J M, Jeurissen Frank J F
Department of Neurology, University Medical Center, Utrecht, The Netherlands.
Neuro Oncol. 2002 Jan;4(1):44-8. doi: 10.1093/neuonc/4.1.44.
Parathyroid carcinoma is an uncommon malignancy. Of the fewer than 400 cases reported, most have been cases of producing parathyroid carcinoma with accompanying hypercalcemia. Only 13 patients with nonproducing parathyroid carcinoma have been described. Nine of these 13 patients had metastatic disease. We report a patient with i.c. metastasis. Distal metastases of producing parathyroid carcinoma are treated surgically to prolong survival and prevent complications of hyperparathyroidism and hypercalcemia. One half of the patients with producing parathyroid carcinoma die within 5 years, mostly because of the complications of hypercalcemia. Nonproducing parathyroid carcinoma compares unfavorably with producing parathyroid carcinoma in terms of tumor progression and prognosis. Few data on choice of therapy in nonproducing parathyroid carcinoma are available. We treated our patient with a combination of radiotherapy and chemotherapy. Treatment was followed by an unexpectedly prolonged survival of 31 months after diagnosis of metastatic disease.
甲状旁腺癌是一种罕见的恶性肿瘤。在报道的不到400例病例中,大多数是伴有高钙血症的分泌型甲状旁腺癌病例。仅描述了13例无分泌功能的甲状旁腺癌患者。这13例患者中有9例发生了转移。我们报告了1例颅内转移患者。分泌型甲状旁腺癌的远处转移采用手术治疗以延长生存期并预防甲状旁腺功能亢进和高钙血症的并发症。分泌型甲状旁腺癌患者中有一半在5年内死亡,主要是由于高钙血症的并发症。在肿瘤进展和预后方面,无分泌功能的甲状旁腺癌与分泌型甲状旁腺癌相比情况不佳。关于无分泌功能的甲状旁腺癌的治疗选择的数据很少。我们对我们的患者采用了放疗和化疗相结合的治疗方法。治疗后,在诊断为转移性疾病后生存期意外延长了31个月。